Ronald Kamdem

Q: What is Ronald Kamdem's success rate?

Ronald Kamdem currently has a success rate of 80.91797826071166.

Q: What is the average return of Ronald Kamdem's calls?

Their stock ratings have generated an average return of 5.5640677790625235.

Morgan Stanley | Real Estate

Ronald Kamdem is an analyst from Morgan Stanley specializing in the Real Estate sector. Ranked #2201 out of 4656 analysts, they have issued 37 stock ratings with a success rate of 80.92% and an average return of 5.56%.

Ronald Kamdem has a well-established track record, with 37 ratings issued in the Real Estate sector. They have consistently delivered a success rate of 80.92% and an average return of 5.56%, underscoring their expertise and ability to identify winning opportunities for investors.

#2201

Out of 4656

Total Ratings

+80.92%

Success Rate

+5.56%

Average Return

Recent Ratings Analysis

NHP

Hold

May 18, 2026

Target

$16.00

Current

$15.04

Performance

0.00%

Ronald Kamdem rated NHP as Equal-Weight on May 18, 2026, setting a price target of 16. The Hold stance appears justified, as shares hovered around 15.04 with a 0.00% move.

NNN

Buy

Apr 28, 2026

Target

$50.00

Current

$44.33

Performance

0.66%

On Apr 28, 2026, NNN was given a Overweight rating by Ronald Kamdem, with a target price of 50. The stock traded sideways with a 0.66% move, keeping the bullish thesis unresolved.

CURB

Buy

Apr 23, 2026

Target

$30.00

Current

$27.73

Performance

-2.12%

CURB received a Overweight rating from Ronald Kamdem on Apr 23, 2026, aiming for 30. Price action was muted, as shares hovered around 27.73 despite the bullish outlook.

REG

Buy

Apr 21, 2026

Target

$88.00

Current

$77.33

Performance

-3.35%

On Apr 21, 2026, Ronald Kamdem published a Overweight outlook on REG, with a target of 88. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 77.33.

JAN

Buy

Apr 14, 2026

Target

$28.00

Current

$26.60

Performance

3.30%

Ronald Kamdem on Apr 14, 2026 assigned JAN a Overweight rating, with a price target of 28. The recommendation remains pending validation as shares consolidate around 26.6.

SNDA

Hold

Apr 07, 2026

Target

$31.00

Current

$36.94

Performance

15.37%

On Apr 07, 2026, Ronald Kamdem reaffirmed SNDA with a Equal-Weight rating, targeting 31. Market strength beyond 36.94 went further than the conservative outlook suggested.

HIW

Hold

Mar 31, 2026

Target

$23.00

Current

$25.72

Performance

20.13%

HIW was rated Equal-Weight by Ronald Kamdem on Mar 31, 2026, with a price objective of 23. Despite caution, upside momentum rewarded risk-takers with gains to 25.72.

VNO

Hold

Mar 31, 2026

Target

$28.00

Current

$31.65

Performance

21.78%

On Mar 31, 2026, Ronald Kamdem initiated coverage on VNO with a Equal-Weight rating and target of 28. The Hold stance underestimated the stock’s strength as it gained 21.78%.

HPP

Sell

Mar 31, 2026

Target

$5.00

Current

$10.80

Performance

82.74%

Ronald Kamdem issued a Underweight recommendation for HPP on Mar 31, 2026, price target set at 5. The bearish outlook played out, as shares fell from 10.8 to 10.8.

WELL

Buy

Feb 18, 2026

Target

$215.00

Current

$212.61

Performance

1.93%

On Feb 18, 2026, WELL was evaluated by Ronald Kamdem, who gave a Overweight rating and target of 215. So far, the Buy call awaits clearer momentum, with shares flat at 212.61.

ARE

Hold

Feb 10, 2026

Target

$55.00

Current

$46.68

Performance

-17.90%

Ronald Kamdem rated ARE as Equal-Weight on Feb 10, 2026, setting a price target of 55. The cautious Hold call aligned with subsequent weakness, as shares slipped 17.90%.

SAFE

Sell

Jan 23, 2026

Target

$14.00

Current

$14.42

Performance

2.12%

On Jan 23, 2026, SAFE was given a Underweight rating by Ronald Kamdem, with a target price of 14. The stock traded sideways with only a 2.12% move, leaving the Sell case unresolved.

UE

Hold

Jan 06, 2026

Target

$22.00

Current

$21.65

Performance

13.71%

UE received a Equal-Weight rating from Ronald Kamdem on Jan 06, 2026, aiming for 22. Investors saw gains of 13.71% that the cautious stance didn’t fully capture.

FVR

Hold

Dec 31, 2025

Target

$14.00

Current

$17.50

Performance

18.56%

On Dec 31, 2025, Ronald Kamdem published a Equal-Weight outlook on FVR, with a target of 14. The Hold call missed some of the bullish momentum as shares advanced toward 14.

BNL

Hold

Dec 29, 2025

Target

$19.00

Current

$20.23

Performance

15.67%

Ronald Kamdem on Dec 29, 2025 assigned BNL a Equal-Weight rating, with a price target of 19. Shares outperformed expectations, climbing 15.67% despite the neutral view.

GLPI

Hold

Dec 24, 2025

Target

$53.00

Current

$47.22

Performance

5.66%

On Dec 24, 2025, Ronald Kamdem reaffirmed GLPI with a Equal-Weight rating, targeting 53. Market strength beyond 47.22 went further than the conservative outlook suggested.

O

Hold

Dec 24, 2025

Target

$65.00

Current

$61.71

Performance

8.89%

O was rated Equal-Weight by Ronald Kamdem on Dec 24, 2025, with a price objective of 65. Despite caution, upside momentum rewarded risk-takers with gains to 61.71.

LINE

Hold

Dec 17, 2025

Target

$46.00

Current

$39.09

Performance

12.33%

On Dec 17, 2025, Ronald Kamdem initiated coverage on LINE with a Equal-Weight rating and target of 46. The Hold stance underestimated the stock’s strength as it gained 12.33%.

EXR

Hold

Dec 05, 2025

Target

$155.00

Current

$139.27

Performance

7.49%

Ronald Kamdem issued a Equal-Weight recommendation for EXR on Dec 05, 2025, price target set at 155. A neutral call gave way to stronger-than-expected performance, closing in on 155.

PSA

Hold

Dec 05, 2025

Target

$290.00

Current

$296.15

Performance

8.85%

On Dec 05, 2025, PSA was evaluated by Ronald Kamdem, who gave a Equal-Weight rating and target of 290. Investors who stayed in despite the Hold saw upside of 8.85%.

NSA

Hold

Dec 05, 2025

Target

$32.00

Current

$41.51

Performance

40.09%

Ronald Kamdem rated NSA as Equal-Weight on Dec 05, 2025, setting a price target of 32. Despite the Hold call, shares climbed 40.09% to 41.51, revealing unexpected momentum.

AHR

Buy

Nov 20, 2025

Target

$55.00

Current

$50.09

Performance

1.75%

On Nov 20, 2025, AHR was given a Overweight rating by Ronald Kamdem, with a target price of 55. The stock traded sideways with a 1.75% move, keeping the bullish thesis unresolved.

PGRE

Hold

Oct 22, 2025

Target

$6.60

Current

$6.60

Performance

1.23%

PGRE received a Equal-Weight rating from Ronald Kamdem on Oct 22, 2025, aiming for 6.6. Shares remained flat at 6.6, aligning with the neutral rating.

CBRE

Buy

Oct 07, 2025

Target

$180.00

Current

$130.44

Performance

-14.57%

On Oct 07, 2025, Ronald Kamdem published a Overweight outlook on CBRE, with a target of 180. Market action contradicted the Buy thesis, as shares slipped to 130.44.

SPG

Hold

Sep 11, 2025

Target

$180.00

Current

$200.42

Performance

8.98%

Ronald Kamdem on Sep 11, 2025 assigned SPG a Equal-Weight rating, with a price target of 180. Shares outperformed expectations, climbing 8.98% despite the neutral view.

VICI

Hold

Jul 08, 2025

Target

$35.00

Current

$28.50

Performance

-13.68%

On Jul 08, 2025, Ronald Kamdem reaffirmed VICI with a Equal-Weight rating, targeting 35. The Hold stance reflected market caution that was later justified.

MAC

Hold

Apr 01, 2025

Target

$19.00

Current

$21.87

Performance

28.19%

MAC was rated Equal-Weight by Ronald Kamdem on Apr 01, 2025, with a price objective of 19. Despite caution, upside momentum rewarded risk-takers with gains to 21.87.

PLD

Buy

Aug 14, 2024

Target

$133.00

Current

$142.31

Performance

15.31%

On Aug 14, 2024, Ronald Kamdem initiated coverage on PLD with a Overweight rating and target of 133. The stock’s climb of 15.31% since the call highlights the foresight in the rating.

Frequency Asked Questions

Who is Ronald Kamdem?

Ronald Kamdem is an analyst from Morgan Stanley specializing in the Real Estate sector.

What is Ronald Kamdem's success rate?

Ronald Kamdem currently has a success rate of +80.92%.

How many ratings has Ronald Kamdem issued?

Ronald Kamdem has issued 37 stock ratings so far.

What is the average return of Ronald Kamdem's calls?

Their stock ratings have generated an average return of +5.56%.

What is Ronald Kamdem's ranking?

Ronald Kamdem is ranked #2201 out of 4656 analysts.

What types of ratings does Ronald Kamdem give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Ronald Kamdem?

You can follow Ronald Kamdem by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Ronald Kamdem?

Their latest rating was a Hold on NHP issued on 2026-05-18.